Environmental neglect: endocrine disruptors as underappreciated but potentially modifiable diabetes risk factors
Sargis RM, Simmons RA
Diabetologia. 2019,62:1811-22
Leggi
What should governments be doing to prevent diabetes throughout the life course?
Timpel P, Harst L, Reifegerste D, et al.
Diabetologia. 2019,62:1842-53
Leggi
Risks of ischaemic heart disease and stroke in meat eaters, fish eaters, and vegetarians over 18 years of follow-up: results from the prospective EPIC-Oxford study
Tong TYN, Appleby PN, Bradbury KE, et al.
BMJ. 2019;366:l4897
Leggi
The diabesity epidemic in the light of evolution: insights from the capacity–load model
Wells JCK
Diabetologia. 2019,62:1740-50
Leggi
Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course
Huebschmann AG, Huxley RR, Kohrt WM, et al.
Diabetologia. 2019, 62:1761–1772
Leggi
Early-life factors contributing to type 1 diabetes
Craig ME, Kim KW, Isaacs SR, et al.
Diabetologia. 2019, 62:1823-34
Leggi
Nuovi corsi FAD real practice
Disponibili cinque corsi FAD real practice Dal 15 settembre saranno disponibili cinque nuovi corsi FAD realizzati tramite modalità “simulation game” relativi a cinque casi clinici “real practice”. Obiettivo dei corsi è supportare i medici nell’individuazione di percorsi ottimali per i pazienti tramite l’applicazione nella pratica quotidiana dei principi e delle…
Leggi
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Husain M, Birkenfeld AL, Donsmark M, et al.
N Engl J Med. 2019;381(9):841-51
Leggi
Impact of Insulin-Treated and Noninsulin-Treated Diabetes Mellitus in All-Comer Patients Undergoing Percutaneous Coronary Interventions with Polymer-Free Biolimus-Eluting Stent (from the RUDI-FREE Registry)
Pepe M, Sardella G, Stefanini GG, et al.
American Journal of Cardiology. Pub online 23 August 2019
Leggi
Ticagrelor In Patients with Diabetes and Stable Coronary Artery Disease with A History of Previous Percutaneous Coronary Intervention (THEMIS-PCI): A Phase 3, Placebo-Controlled, Randomised Trial
Bhatt DL, Steg PG, Mehta SR, et al.
Lancet Diabetes Endocrinol. Pub online 1 September 2019
Leggi